LifeActive Bio is a biomaterials company that provides an innovative Molecular Administration Platform and XnanodeX formulation technology to enhance the delivery and systemic absorption of therapeutic compounds and cosmetic ingredients through the skin.
LifeActive Bio is a pre-clinical biomaterials company that specializes in advanced molecular delivery technology. The company has developed a proprietary, patent-pending system known as the Molecular Administration Platform, which utilizes a natural lipo-surfactant microemulsion to encapsulate molecules for direct absorption through the skin. This technology is designed to bypass traditional first-pass metabolism and eliminate the need for invasive administration methods. Beyond its therapeutic applications, the company also offers the XnanodeX Clean Label Base, a formulation platform specifically engineered for the cosmetics and personal care industries, enabling brands to develop products with streamlined, clean-label ingredient profiles.
The company's technology aims to improve the delivery and bioavailability of both existing and new therapeutic compounds, with potential applications spanning cardiovascular, metabolic, and respiratory health, as well as mental wellness and oncology. By enabling more efficient nutrient and drug absorption without needles or invasive devices, LifeActive Bio seeks to extend human quality of life and enhance therapeutic outcomes. The company operates as a scalable platform, providing white-labeling and licensing opportunities that allow brand and manufacturing partners to integrate its proprietary emulsion technology into their product lines, significantly reducing the time required to move from concept to market-ready samples.